# This Study Aims to Assess the Performances of Optical Blood Pressure Monitoring Device, tBPC Product With Reference to ISO 81060-3:2022

> **NCT06815614** · — · COMPLETED · sponsor: **Taiwan Biophotonic Corporation** · enrollment: 40 (actual)

## Conditions studied

- Blood Pressure
- Blood Pressure Variability

## Interventions

- **DEVICE:** A Photoplethysmography-Based Continuous Automated Non-Invasive Sphygmomanometer

## Key facts

- **NCT ID:** NCT06815614
- **Lead sponsor:** Taiwan Biophotonic Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-29
- **Primary completion:** 2024-09-19
- **Final completion:** 2024-11-26
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06815614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06815614, "This Study Aims to Assess the Performances of Optical Blood Pressure Monitoring Device, tBPC Product With Reference to ISO 81060-3:2022". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06815614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*